The global capsule endoscopy market size was valued at USD 465.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2021 to 2028. The increasing prevalence of cancer, growing global geriatric population base, rising demand for minimally invasive diagnostic procedures, and introduction of technologically advanced capsules are the major factors bolstering the market growth. In addition, rising healthcare expenditure levels triggering the need for effective diagnostic procedures for cancer and supportive government initiatives are a few factors expected to boost the market growth.
Benefits provided by capsule endoscopies such as painless visualization of gastrointestinal tract images, precise diagnosis, and faster results have increased their adoption in recent years. In addition, the introduction of technologically advanced wireless capsules with enhanced features such as longer battery life, enhanced data storage capability, WiFi-enabled devices, ergonomic designs, easy transmission, larger frame rate, 360-degree panoramic view, and improved image quality are the other factors propelling the market growth during the forecast period.
In addition, the rising geriatric population base is anticipated to provide this market with a strong platform of growth over the coming years. Aging significantly increases the risk of gastrointestinal disorders such as inflammatory bowel disease, Crohn’s disease, colorectal cancer, and appendicitis. Furthermore, the growing prevalence of cancer in older as well as younger adults in recent years and increasing adoption of screening tests, including capsule endoscopy for detection is likely to fuel market growth. According to statistics provided by Cancer.Net in 2021, it is estimated that around 149,500 adults in the U.S. will be diagnosed with colorectal cancer this year. Such increasing prevalence signifies the growth of the market shortly.
Furthermore, the rising adoption of minimally invasive surgical interventions has further propelled the utilization of capsule endoscopic systems and wireless capsules, majorly for detection or diagnosis of gastrointestinal issues such as OGIB (obscure GI tract bleeding), Crohn’s disease, cancer, and small intestine tumor. Capsule endoscopy provides highly efficient and fast results concerning screening of such gastrointestinal conditions, thereby boosting the adoption and leading to market growth.
Moreover, some of the limitations of capsule endoscopy such as capsule retention and utilization limited to diagnostic purpose act as hurdles in the growth of the market for capsule endoscopy. The risk of retention of the capsule may require endoscopic retrieval or rarely surgical resection. For instance, as per a 2017 study published in Annals of Translational Medicine, capsule retention occurs approximately in 2% of the patients undergoing a small bowel capsule endoscopic procedure. This creates an obstacle in the adoption of capsule endoscopes. However, with technological advancements and better-designed wireless capsules, the retention rate is anticipated to reduce, thereby fueling the market growth.
In addition, the COVID-19 pandemic has substantially impacted the capsule endoscopy market. The postponement, delay, cancellation, and reduction in the number of elective surgeries performed during the COVID-19 pandemic have impacted significantly the market. In addition, changing regulations with regards to surgical interventions and endoscopic screening procedures, and disruptions in the supply chain are some of the key factors that have hindered the growth of the market for capsule endoscopy during the pandemic.
Furthermore, capsule endoscopy training for medical professionals has also impacted drastically. Many institutions have opted for e-learning modules for training. However, with situations heading toward normalcy, the training sessions are likely to restore to face-to-face training sessions. Moreover, the advantages provided by capsule endoscopy are anticipated to boost the growth of the market for capsule endoscopy post-pandemic. For instance, according to a 2021 cohort study of 146 patients (74 COVID-19 positives) published in JAMA Network, active bleeding was identified more frequently using video capsule endoscopy as the first strategy (around 59.5%), as compared to the traditional endoscopic detection process. Hence, such instances signify the growth of the market post-pandemic situation.
Based on product type, the capsule endoscopes segment dominated the market for capsule endoscopy and accounted for the largest revenue share of 75.7% in 2020. In addition, this segment is anticipated to grow at the fastest rate during the forecast period. This high share and growth rate is attributable to advantages provided by them in the diagnosis or detection of complex health conditions, such as gastrointestinal disorders, cancer, Crohn’s disease, and other small bowel disorders. Furthermore, the increasing preference of medical and healthcare professionals towards utilization of capsule endoscopy for faster and efficient diagnosis is yet another factor boosting segment growth.
Moreover, the capsule endoscopes segment is segmented into types of capsules, such as small bowel, esophageal, and colon endoscopes. Small bowel capsules contribute to the highest revenue share of the market in 2020 due to their rising utilization in the diagnosis and screening of medical conditions such as inflammatory bowel disease, Crohn’s disease, obscure GI tract bleeding (OGIB), and small bowel neoplastic lesions. In addition, a growing preference toward less-invasive screening techniques is anticipated to support the growth of the market for capsule endoscopy during the forecast period.
Based on the application, the OGIB segment held the highest revenue share of 58.1% in 2020, due to numerous advantages provided by capsule endoscopy in the diagnosis and detection of OGIB. In addition, benefits such as real-time visualization, image capturing, and analysis of the entire small intestine and reliable and precise results help increase the adoption of capsule endoscopes for OGIB. Furthermore, the shift in trend towards the adoption of capsule-based endoscopy screening for OGIB as compared to conventional methods, such as double-balloon enteroscopy, is further supporting the growth of the segment.
Furthermore, the Crohn’s disease segment is anticipated to grow at a substantial rate during the forecast period due to the increasing utilization of capsule endoscopes for the detection of Crohn’s disease. It is one of the most common types of Inflammatory Bowel Diseases (IBD) and the rising prevalence of IBD, along with Crohn’s disease is anticipated to support market growth during the forecast period. Canada has one of the highest incidence rates of IBD, including Crohn’s disease and ulcerative colitis. For instance, according to 2018 statistics provided by Crohn’s and Colitis Canada, around 270,000 people in the country are living with IBD, out of which 135,000 people are living with Crohn’s disease. It is a substantially high number. In addition, the IBD prevalence rate is anticipated to increase by 50% by 2030, with around 400,000 Canadians getting diagnosed with IBD.
In 2020, based on end-use, the hospitals segment dominated the market for capsule endoscopy and accounted for the highest revenue share of 47.8%. It is attributed to the substantially large adoption, utilization of capsule endoscopy services, and such endoscopes in the hospitals compared to the other healthcare systems. In addition, favorable reimbursement policies provided by the government are further boosting the market growth. Furthermore, hospitals are usually the primary health systems in the majority of the countries, and hence the number of screenings performed in hospitals is higher, thereby signifying greater adoption and demand.
In addition, the ambulatory surgery centers/clinics segment is expected to grow at the fastest rate over the forecast period. Minimal time required for capsule endoscopy screening procedures and faster results are the key factors that are supporting the demand for these procedures in the ambulatory surgical centers/clinics systems. It is further affirmatively impacting the market growth.
North America dominated the market for capsule endoscopy and accounted for the largest revenue share of 44.0% in 2020 due to a rising preference for minimally invasive screening procedures, along with the adoption of technologically enhanced products and systems. In addition, improved healthcare infrastructure is yet another factor propelling the market growth. Moreover, rising awareness regarding early screening of diseases such as gastrointestinal disorders, cancer, and other chronic conditions is also one of the prominent factors supporting market growth in the region.
Furthermore, in Asia Pacific, the market for capsule endoscopy is expected to exhibit lucrative growth over the forecast period. It is attributable to the higher demand for capsule-based endoscopic technologies for screening procedures in this region. In addition, some of the other key factors supporting growth are improving healthcare infrastructure and the rising geriatric population. Moreover, significant economic development in the region is one of the pioneering factors responsible for attracting international investments. The presence of major players along with the constantly developing start-up landscape is further encouraging market growth.
There is significant competition amongst the existing players due to the growing demand for capsule-based endoscopes and endoscopy systems for various screening and diagnostic procedures. In addition, technological advancements in the field of endoscopy by key players is further increasing the competition. Some of the key players operating in the market are Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd, RF System lab, and CapsoVision.
Furthermore, strategic alliances with other market players, such as mergers and acquisitions, product launches, partnerships, and growing R&D in the area of capsule-based endoscopic technologies are some of the initiatives being undertaken by key market players to increase their market shares. In 2020, Medtronic announced its partnership with Amazon for home delivery of its capsule endoscope-PillCam Genius. It will help in increasing its penetration at a global level and enhancing patient comfort and satisfaction. Some of the prominent players of the capsule endoscopy market include:
Given Imaging (Medtronic Plc)
Olympus Corporation
IntroMedic, Co. Ltd.
Chongqing Jinshan Science & Technology (Group) Co., Ltd.
CapsoVision
RF System lab
Report Attribute |
Details |
Market size value in 2021 |
USD 524.7 million |
Revenue forecast in 2028 |
USD 939.5 million |
Growth Rate |
CAGR of 8.7% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2014 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; Switzerland; Denmark; China; Japan; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait; Israel; Qatar |
Key companies profiled |
Given Imaging (Medtronic); IntroMedic Co., Ltd.; Olympus Corporation; Chongqing Jinshan Science & Technology (Group) Co., Ltd.; RF System lab; CapsoVision |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global capsule endoscopy market report on the basis of product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2028)
Capsule Endoscopes
Small Bowel
Esophageal
Colon
Systems
Application Outlook (Revenue, USD Million, 2014 - 2028)
OGIB (obscure GI tract bleeding)
Crohn’s Disease
Small Intestine Tumor
Others
End-use Outlook (Revenue, USD Million, 2014 - 2028)
Hospitals
Ambulatory surgery centers
Other end-uses
Regional Outlook (Revenue, USD Million, 2014 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
Italy
France
Spain
Russia
Switzerland
Denmark
Asia Pacific
India
China
Japan
Australia
New Zealand
Thailand
Indonesia
Malaysia
Vietnam
Philippines
Latin America
Mexico
Brazil
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
Kuwait
Israel
Qatar
b. The global capsule endoscopy market size was estimated at USD 465.5 million in 2020 and is expected to reach USD 524.7 million in 2021.
b. The global capsule endoscopy market is expected to grow at a compound annual growth rate of 8.7% from 2021 to 2028 to reach USD 939.5 million by 2028.
b. North America dominated the capsule endoscopy market with a share of 44.0% in 2020. This is attributable to rising prevalence rate of GI disorders & colorectal cancer coupled with advanced healthcare infrastructure, the presence of favorable reimbursement policies and increasing adoption of minimally invasive capsule endoscopy by patients.
b. Some key players operating in the capsule endoscopy market include Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd, RF System lab, and CapsoVision.
b. Key factors that are driving the capsule endoscopy market growth include increasing prevalence of gastrointestinal diseases, colorectal cancer, demand for faster and accurate diagnostics tools, and the presence of supportive government initiatives coupled with rising global geriatric population base.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.